Literature DB >> 24311783

MicroRNAs contribute to induced pluripotent stem cell somatic donor memory.

Marianna Vitaloni1, Julian Pulecio, Josipa Bilic, Bernd Kuebler, Leopoldo Laricchia-Robbio, Juan Carlos Izpisua Belmonte.   

Abstract

Induced pluripotent stem cells (iPSCs) maintain during the first few culture passages a set of epigenetic marks and metabolites characteristic of their somatic cell of origin, a concept defined as epigenetic donor memory. These residual somatic features are lost over time after extensive culture passaging. Therefore, epigenetic donor memory may be responsible for the higher differentiation efficiency toward the tissue of origin observed in low passage iPSCs versus high passage iPSC or iPSCs derived from a different tissue source. Remarkably, there are no studies on the relevance of microRNA (miRNA) memory following reprogramming, despite the established role of these molecules in the context of pluripotency and differentiation. Using hematopoietic progenitors cells as a model, we demonstrated that miRNAs play a central role in somatic memory retention in iPSCs. Moreover, the comparison of the miRNA expression profiles among iPSCs from different sources allowed for the detection of a set of candidate miRNAs responsible for the higher differentiation efficiency rates toward blood progenitors observed in low passage iPSCs. Combining bioinformatic predictive algorithms with biological target validation, we identified miR-155 as a key player for the in vitro differentiation of iPSC toward hematopoietic progenitors. In summary, this study reveals that during the initial passages following reprogramming, iPSCs maintained the expression of a miRNA set exclusive to the original somatic population. Hence the use of these miRNAs might hold a direct application toward our understanding of the differentiation process of iPSCs toward hematopoietic progenitor cells.

Entities:  

Keywords:  Computational Biology; Differentiation; Hematopoietic Progenitor Cell; Induced Pluripotent Stem (iPS) Cell; Induced Pluripotent Stem Cells; MicroRNA

Mesh:

Substances:

Year:  2013        PMID: 24311783      PMCID: PMC3900956          DOI: 10.1074/jbc.M113.538702

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Summaries of Affymetrix GeneChip probe level data.

Authors:  Rafael A Irizarry; Benjamin M Bolstad; Francois Collin; Leslie M Cope; Bridget Hobbs; Terence P Speed
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

2.  Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis.

Authors:  Koichi Akashi; Xi He; Jie Chen; Hiromi Iwasaki; Chao Niu; Brooke Steenhard; Jiwang Zhang; Jeff Haug; Linheng Li
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

3.  CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control.

Authors:  Robert W Georgantas; Richard Hildreth; Sebastien Morisot; Jonathan Alder; Chang-gong Liu; Shelly Heimfeld; George A Calin; Carlo M Croce; Curt I Civin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-09       Impact factor: 11.205

Review 4.  MicroRNAs as regulators of mammalian hematopoiesis.

Authors:  Chang-Zheng Chen; Harvey F Lodish
Journal:  Semin Immunol       Date:  2005-04       Impact factor: 11.130

5.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

6.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

8.  Chromatin signatures of pluripotent cell lines.

Authors:  Véronique Azuara; Pascale Perry; Stephan Sauer; Mikhail Spivakov; Helle F Jørgensen; Rosalind M John; Mina Gouti; Miguel Casanova; Gary Warnes; Matthias Merkenschlager; Amanda G Fisher
Journal:  Nat Cell Biol       Date:  2006-03-29       Impact factor: 28.824

9.  Direct homo- and hetero-interactions of MeCP2 and MBD2.

Authors:  Annette Becker; Lena Allmann; Maria Hofstätter; Valentina Casà; Patrick Weber; Anne Lehmkuhl; Henry D Herce; M Cristina Cardoso
Journal:  PLoS One       Date:  2013-01-15       Impact factor: 3.240

10.  De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells.

Authors:  Yuko Tadokoro; Hideo Ema; Masaki Okano; En Li; Hiromitsu Nakauchi
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

View more
  20 in total

Review 1.  Transcription factor-mediated reprogramming: epigenetics and therapeutic potential.

Authors:  Jaber Firas; Xiaodong Liu; Sue Mei Lim; Jose M Polo
Journal:  Immunol Cell Biol       Date:  2015-02-03       Impact factor: 5.126

Review 2.  Placenta-based therapies for the treatment of epidermolysis bullosa.

Authors:  Christopher Nevala-Plagemann; Catherine Lee; Jakub Tolar
Journal:  Cytotherapy       Date:  2015-03-18       Impact factor: 5.414

3.  Induced Pluripotent Stem Cell Differentiation and Three-Dimensional Tissue Formation Attenuate Clonal Epigenetic Differences in Trichohyalin.

Authors:  Anastasia Petrova; Antonio Capalbo; Laureen Jacquet; Simon Hazelwood-Smith; Dimitra Dafou; Carl Hobbs; Matthew Arno; Alessio Farcomeni; Liani Devito; Heba Badraiq; Michael Simpson; John A McGrath; Wei-Li Di; Jeffrey B Cheng; Theodora M Mauro; Dusko Ilic
Journal:  Stem Cells Dev       Date:  2016-08-30       Impact factor: 3.272

4.  Identification of a foetal epigenetic compartment in adult human kidney.

Authors:  John K Wiencke; Ze Zhang; Devin C Koestler; Lucas A Salas; Annette M Molinaro; Brock C Christensen; Karl T Kelsey
Journal:  Epigenetics       Date:  2021-03-30       Impact factor: 4.528

5.  Deprogram and reprogram to solve the riddle of insulin resistance.

Authors:  Victoria L Tokarz; Paul Delgado-Olguín; Amira Klip
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

Review 6.  Amyotrophic lateral sclerosis - cell based therapy and novel therapeutic development.

Authors:  Changsung Kim; Hee Chul Lee; Jung-Joon Sung
Journal:  Exp Neurobiol       Date:  2014-09-18       Impact factor: 3.261

Review 7.  Tapping Stem Cells to Target AMD: Challenges and Prospects.

Authors:  Caroline Brandl; Felix Grassmann; Julia Riolfi; Bernhard H F Weber
Journal:  J Clin Med       Date:  2015-01-29       Impact factor: 4.241

Review 8.  Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease.

Authors:  Mario Notari; Julián Pulecio; Ángel Raya
Journal:  Biomed Res Int       Date:  2015-06-28       Impact factor: 3.411

Review 9.  Concise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem Cells.

Authors:  Youssef Hibaoui; Anis Feki
Journal:  J Clin Med       Date:  2015-04-15       Impact factor: 4.241

Review 10.  Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application.

Authors:  Changsung Kim
Journal:  Blood Res       Date:  2014-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.